Hui N Yu from Newtown, PA, age 63

Medicine Doctors

Hui Ying Yu

view source

Specialties:

Neurology, Neuromuscular Medicine

Work:

Winthrop Univ Hosp NeurologyWinthrop Neurosience Medical PC
200 Old Country Rd STE 370, Mineola, NY 11501
(516)6634525 (phone), (516)6634532 (fax)

Education:

Medical School
Bethune Med Univ, Changchun City, Jilin, China
Graduated: 1986

Procedures:

Neurological Testing
Sleep and EEG Testing

Conditions:

Carpel Tunnel Syndrome
Epilepsy
Ischemic Stroke
Migraine Headache
Multiple Sclerosis (MS)

Languages:

Chinese
English
Polish

Description:

Dr. Yu graduated from the Bethune Med Univ, Changchun City, Jilin, China in 1986. She works in Mineola, NY and specializes in Neurology and Neuromuscular Medicine. Dr. Yu is affiliated with Winthrop University Hospital.

Hui Yu

view source

Specialties:

Anatomic Pathology & Clinical Pathology

Name / Title

Company / Classification

Phones & Addresses

Hui Yu
President

USA MESON FERTILIZER (YANTAI) INC

Us Patents

Pharmaceutical Compositions For Poorly Water-Soluble Compounds
view source
US Patent:

20200009125, Jan 9, 2020
Filed:

Jun 17, 2019
Appl. No.:

16/443324
Inventors:

- North Brunswick NJ, US
Kaoru Tominaga - North Brunswick NJ, US
Hui Yu - Newtown PA, US
International Classification:

A61K 31/4545
A61K 31/4365
A61K 31/196
A61K 31/192
A61K 9/14
Abstract:

This present invention is concerned with novel solid dispersion pharmaceutical compositions for preparation of composition which is comprised of a compound with poor water solubility (a weakly basic, neutral and/or non-ionizable, or a weakly acidic compound), water-soluble polymer(s), pH-sensitive polymer(s) (either enteric polymer or gastric-soluble polymer that is soluble at gastric fluid and insoluble at intestine pH range such as Eudragit E), and/or pharmaceutical acceptable surfactant(s) that would improve the solubility/dissolution of the compound in aqueous media of both low and neutral pHs and provide a relative pH-independent dissolution profile.

Pharmaceutical Compositions For Poorly Water-Soluble Compounds
view source
US Patent:

20170252332, Sep 7, 2017
Filed:

May 10, 2017
Appl. No.:

15/591829
Inventors:

- North Brunswick NJ, US
Kaoru Tominaga - North Brunswick NJ, US
Hui Yu - Newtown PA, US
International Classification:

A61K 31/4545
A61K 31/4365
A61K 31/192
A61K 9/14
A61K 31/196
Abstract:

This present invention is concerned with novel solid dispersion pharmaceutical compositions for preparation of composition which is comprised of a compound with poor water solubility (a weakly basic, neutral and/or non-ionizable, or a weakly acidic compound), water-soluble polymer(s), pH-sensitive polymer(s) (either enteric polymer or gastric-soluble polymer that is soluble at gastric fluid and insoluble at intestine pH range such as Eudragit E), and/or pharmaceutical acceptable surfactant(s) that would improve the solubility/dissolution of the compound in aqueous media of both low and neutral pHs and provide a relative pH-independent dissolution profile.

Pharmaceutical Compositions For Poorly Water-Soluble Compounds
view source
US Patent:

20150182457, Jul 2, 2015
Filed:

Dec 30, 2014
Appl. No.:

14/585700
Inventors:

- North Brunswick NJ, US
Kaoru Tominaga - North Brunswick NJ, US
Hui Yu - Newtown PA, US
International Classification:

A61K 9/10
A61K 47/38
A61K 31/4545
A61K 47/26
A61K 31/196
A61K 31/192
A61K 31/4365
A61K 47/32
Abstract:

This present invention is concerned with novel solid dispersion pharmaceutical compositions for preparation of composition which is comprised of a compound with poor water solubility (a weakly basic, neutral and/or non-ionizable, or a weakly acidic compound), water-soluble polymer(s), pH-sensitive polymer(s) (either enteric polymer or gastric-soluble polymer that is soluble at gastric fluid and insoluble at intestine pH range such as Eudragit E), and/or pharmaceutical acceptable surfactant(s) that would improve the solubility/dissolution of the compound in aqueous media of both low and neutral pHs and provide a relative pH-independent dissolution profile.